Monday, October 12, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Lam Research: Analyst Price Targets Soar to $425 as the Stock Holds Its Breath

SiterGedge by SiterGedge
July 11, 2026
in AI & Quantum Computing, Analysis, Semiconductors
0
Lam Research Stock
0
SHARES
43
VIEWS
Share on FacebookShare on Twitter

The semiconductor equipment maker Lam Research finds itself in an odd spot. Its shares have barely budged over the past week — gaining just 0.34% to close Friday at $352.61 — yet Wall Street analysts are racing to raise their price targets to levels that imply a 20% upside. Stifel’s Brian Chin led the charge, boosting his target to $425 from $325, a $100 leap that reflects a growing conviction that the chip-equipment cycle has further to run.

Chin’s rationale rests on a simple supply-demand imbalance: AI chip demand continues to outstrip available capacity, handing equipment suppliers unusual pricing power. He forecasts Lam Research will report system revenue of roughly $4.6 billion for the fiscal fourth quarter, representing a 23% sequential jump. And he expects that pricing leverage to persist into 2027.

The bullish mood isn’t confined to Stifel. TD Cowen and Mizuho also lifted their targets this week, pencilling in a range of $400 to $425. Their reasoning echoes Chin’s: the industry’s shift toward gate-all-around transistors and advanced packaging makes chip fabrication more complex — and more equipment-intensive. The entire wafer-fabrication-equipment sector is benefiting; Stifel simultaneously raised targets for Applied Materials to $650 and for KLA to $270.

Yet the stock itself remains remarkably subdued. At $352.61, it still sits 19.59% below the 52-week high of $438.50 reached in late June. The 14-day relative strength index of 49.5 sits squarely in neutral territory, neither overbought nor oversold. The share price is 7.07% above its 50-day moving average of $329.33 and a towering 52% above the 200-day average of $230.77 — a sign of the steep run that preceded the current consolidation.

A market split between optimism and caution

That consolidation, while mild on the surface, masks a broader debate. The week began under a cloud as investors fretted about overcapacity in AI infrastructure. Sentiment turned midweek when a South Korean memory-chip maker reported heavy oversubscription for its upcoming IPO, a signal that institutional appetite for high-bandwidth memory remains intense. Competitors’ upbeat commentary about a multi-year expansion cycle in wafer-fab equipment added fuel to the recovery.

Should investors sell immediately? Or is it worth buying Lam Research?

Lam Research supplies the etching and deposition tools that are essential for advanced logic and memory chips, giving it direct exposure to these trends. The company also recently opened a packaging center in Europe, further positioning itself for the shift toward heterogeneous integration.

But not everything points upward. Insider sales over the past three months have totalled roughly $59.4 million, a detail that gives some traders pause, particularly with the stock trading at a price-to-earnings multiple of around 65 — well above historical norms for the sector. The company’s market capitalisation stands at approximately €364.7 billion, and its 30-day annualised volatility of 93.67% underscores the stock’s dramatic swings.

What investors are watching next

Lam Research is set to report its next quarterly results at the end of July 2026. The focus will be on whether management’s guidance matches the rosy analyst forecasts — and on any updated outlook for wafer-fab equipment spending. Industry projections see that capex reaching between $145 billion and $150 billion in 2026, with a potential climb to $225 billion by 2028.

For now, the market appears to be waiting. The stock has climbed 90.54% year to date and 249.60% over the past 12 months, so the recent sideways drift is as likely to reflect profit-taking as it is skepticism. If the July earnings call delivers the upside Stifel predicts, the gap between current price and analyst targets may close quickly. If not, the current calm could prove to be a prelude to a reset.

Ad

Lam Research Stock: Buy or Sell?! New Lam Research Analysis from October 11 delivers the answer:

The latest Lam Research figures speak for themselves: Urgent action needed for Lam Research investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 11.

Lam Research: Buy or sell? Read more here...

Tags: Lam Research
SiterGedge

SiterGedge

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Next Post
Valneva Stock

Valneva’s Binary Outlook: A Broken Commercial Business Versus a Potentially Blockbuster Pipeline

CrowdStrike Stock

CrowdStrike’s Post-Split Volatility Masks Sector-Wide Cybersecurity Selloff as Analysts Stay Bullish

Sellas Life Sciences Stock

Sellas Life Sciences Holds Its Breath as a Leukemia Trial Nears the Finish Line

Recommended

Uranium Energy Stock

Uranium Energy’s Vertical Integration Strategy: A Game Changer or Gamble?

1 year ago
Plug Power Stock

The Hydrogen Conundrum: Why Plug Power’s Operational Wins Aren’t Translating to Market Gains

12 months ago
Industrial Metals and Mining stock Trading

Brett Argirakis Demonstrates Confidence in Minerals Technologies Through Stock Option Exercise

3 years ago
Lockheed Stock

Lockheed Martin Shares: Can New Contracts Reverse the Slide?

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Records on Narrow Shoulders as the 10-Year Yield Tops 5.3%

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

Cash Flow Beats Backlog as Banks Brace for Earnings

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

From GPUs to Guardrails: Q4’s Security Rotation Begins

Trending

Humana Stock
Newsletter

SpaceX Hits the Carriers, Medicare Stars Lift Humana

by Stephanie Dugan
October 10, 2026
0

Dear readers, The S&P 500 closed its third straight weekly gain on Friday, just below Tuesday's record....

TSMC Stock

OpenAI’s Miss Exposes AI’s Debt Load as Yields Climb

October 9, 2026
Bank of America Stock

Banks Slump 13% Ahead of Profit Gains of Up to 20%

October 8, 2026
Zeta Global Stock

Records on Narrow Shoulders as the 10-Year Yield Tops 5.3%

October 7, 2026
PepsiCo Stock

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

October 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • SpaceX Hits the Carriers, Medicare Stars Lift Humana
  • OpenAI’s Miss Exposes AI’s Debt Load as Yields Climb
  • Banks Slump 13% Ahead of Profit Gains of Up to 20%

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com